Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.

Journal of clinical microbiology - 1 Aug 2002

Wilson K E, Cassiday P K, Popovic T, Sanden G N

Abstract excerpt

Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess the potential public health impact of erythromycin-resistant B. pertussis, we used the disk diffusion assay to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bordetella pertussis
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Erythromycin

Share to Microbial Sensitivity Tests

Share to Phenotype

Share to Population Surveillance

Share to Whooping Cough

Source

Open in PubMed Open full text

Identifiers

PMID: 12149356
DOI: 10.1128/JCM.40.8.2942-2944.2002
PMCID: PMC120648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.PMID 12149356Read ↗

The effect of erythromycin in Macrolide-Resistant Bordetella pertussis: Inhibitory on Growth, Toxin Expression, and VirulenceSemantic proximity Read ↗

Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Bordetella pertussis Strains — Beijing, China, 2022–2023Semantic proximity Read ↗

Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.Semantic proximity Read ↗

Macrolide Susceptibility and Molecular Characteristics of Bordetella PertussisSemantic proximity Read ↗

The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.Semantic proximity Read ↗

Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.Semantic proximity Read ↗

Clinical and Microbiological Characteristics of macrolide-resistant Bordetella pertussis Infection: A case series in Osaka, Japan (2024-2025).Semantic proximity Read ↗

Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).Semantic proximity Read ↗

Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.Semantic proximity Read ↗

Significant Decrease in Pertactin-Deficient Bordetella pertussis Isolates, Japan.Semantic proximity Read ↗

Macrolide susceptibility and molecular characteristics of Bordetella pertussis.Semantic proximity Read ↗

Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.